Skip to content

The effect of injecting of lidocaine and adrenaline in myometrium on bleeding during myomectomy

Evaluation of the effects of local- intra myometrial injection of lidocaine plus adrenaline in the amount of blood loss during myomectomy

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20090525001946N10
Enrollment
60
Registered
2019-07-30
Start date
2019-07-06
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding during myomectomy.

Interventions

Intervention 1: Intervention group: In the treatment group, before the removal of the myoma, and after monitoring is done by the anesthetic team, 40 milliliters of the local anesthetic solution contai

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women of reproductive age candidate for Myomectomy Patients with symptomatic Myoma without responding to medical treatments (laparotomy, infertility for more than 3 years with myomectomy indication) Pain and pelvic pressure Urination frequency and constipation The size of the uterus is less than 18 weeks. Not accepting hysterectomy Myoma grade 6-2 based on ultrasound The cause of myoma bleeding is detected

Exclusion criteria

Exclusion criteria: Adenomyosis of cervical myomas or peduncle Coagulation problems and recurrent vascular thrombosis Ischemic heart disease, cardiomyopathy Women with multiple myomas Lidocaine susceptibility c Uncontrolled hypertension Hyperthyroidism Seizure Recent use of ergot alkaloids and vasoconstrictors, triangular antidepressants and monoamine oxidase inhibitors. Liver disease Diabetes, asthma, COPD Malignancy

Design outcomes

Primary

MeasureTime frame
The amount of bleeding of patients during myomectomy surgery. Timepoint: After the operation, according to the information recorded in the patient's file. Method of measurement: With the difference in hemoglobin (g / dl) before and after operation and the number of transfused blood pack cells during operation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMandana Mansur Ghanaie

Rasht University of Medical Sciences

m_m_ghanaie@gums.ac.ir+98 13 1322 5624

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026